$PAHC
PHIBRO ANIMAL HEALTH CORP

2021 Q4 Form 10-Q Financial Statement

#000141057822000100 Filed on February 09, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4
Revenue $232.7M $206.1M
YoY Change 12.89% -3.67%
Cost Of Revenue $162.0M $137.9M
YoY Change 17.52% -4.85%
Gross Profit $70.67M $68.27M
YoY Change 3.53% -1.21%
Gross Profit Margin 30.37% 33.11%
Selling, General & Admin $48.38M $48.38M
YoY Change 0.01% -2.26%
% of Gross Profit 68.45% 70.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.001M $8.088M
YoY Change -1.08% -0.74%
% of Gross Profit 11.32% 11.85%
Operating Expenses $48.38M $48.38M
YoY Change 0.01% -2.26%
Operating Profit $22.29M $19.89M
YoY Change 12.09% 1.43%
Interest Expense $3.102M $3.476M
YoY Change -10.76% -11.71%
% of Operating Profit 13.91% 17.48%
Other Income/Expense, Net
YoY Change
Pretax Income $23.53M $16.05M
YoY Change 46.59% -4.99%
Income Tax $6.065M $3.251M
% Of Pretax Income 25.78% 20.25%
Net Earnings $17.47M $12.80M
YoY Change 36.43% 7.63%
Net Earnings / Revenue 7.5% 6.21%
Basic Earnings Per Share $0.43 $0.32
Diluted Earnings Per Share $0.43 $0.32
COMMON SHARES
Basic Shares Outstanding 40.50M 40.45M
Diluted Shares Outstanding 40.50M 40.50M

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.49M $95.50M
YoY Change -0.02% 26.99%
Cash & Equivalents $63.39M $34.53M
Short-Term Investments $32.10M $61.00M
Other Short-Term Assets $39.85M $42.28M
YoY Change -5.75% 43.8%
Inventory $230.8M $213.3M
Prepaid Expenses
Receivables $142.5M $126.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $508.6M $477.2M
YoY Change 6.59% 7.11%
LONG-TERM ASSETS
Property, Plant & Equipment $154.6M $150.3M
YoY Change 2.82% -10.41%
Goodwill $52.68M $52.68M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $4.717M $4.638M
YoY Change 1.7% -55.4%
Other Assets $75.11M $56.84M
YoY Change 32.15% 56.58%
Total Long-Term Assets $340.3M $326.5M
YoY Change 4.25% -4.76%
TOTAL ASSETS
Total Short-Term Assets $508.6M $477.2M
Total Long-Term Assets $340.3M $326.5M
Total Assets $849.0M $803.7M
YoY Change 5.64% 1.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $80.66M $63.31M
YoY Change 27.42% 8.59%
Accrued Expenses $72.84M $81.72M
YoY Change -10.87% 83.64%
Deferred Revenue $1.675M $1.868M
YoY Change -10.33%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $13.13M $21.90M
YoY Change -40.07% 40.38%
Total Short-Term Liabilities $166.6M $166.9M
YoY Change -0.16% 13.46%
LONG-TERM LIABILITIES
Long-Term Debt $387.3M $364.9M
YoY Change 6.14% 2.1%
Other Long-Term Liabilities $55.72M $58.48M
YoY Change -4.73% 2.78%
Total Long-Term Liabilities $55.72M $58.48M
YoY Change -4.73% -85.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $166.6M $166.9M
Total Long-Term Liabilities $55.72M $58.48M
Total Liabilities $609.7M $590.3M
YoY Change 3.28% 3.4%
SHAREHOLDERS EQUITY
Retained Earnings $232.3M $198.5M
YoY Change 17.05%
Common Stock $135.8M $136.7M
YoY Change -0.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $239.3M $213.3M
YoY Change
Total Liabilities & Shareholders Equity $849.0M $803.7M
YoY Change 5.64% 1.95%

Cashflow Statement

Concept 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income $17.47M $12.80M
YoY Change 36.43% 7.63%
Depreciation, Depletion And Amortization $8.001M $8.088M
YoY Change -1.08% -0.74%
Cash From Operating Activities $20.12M $26.91M
YoY Change -25.22% -16.14%
INVESTING ACTIVITIES
Capital Expenditures -$7.690M -$7.320M
YoY Change 5.05% -13.27%
Acquisitions
YoY Change
Other Investing Activities $25.26M -$300.0K
YoY Change -8519.33% -98.83%
Cash From Investing Activities $17.57M -$7.620M
YoY Change -330.55% -77.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -14.58M -16.54M
YoY Change -11.87% -38.74%
NET CHANGE
Cash From Operating Activities 20.12M 26.91M
Cash From Investing Activities 17.57M -7.620M
Cash From Financing Activities -14.58M -16.54M
Net Change In Cash 23.11M 2.750M
YoY Change 740.51% -109.45%
FREE CASH FLOW
Cash From Operating Activities $20.12M $26.91M
Capital Expenditures -$7.690M -$7.320M
Free Cash Flow $27.81M $34.23M
YoY Change -18.75% -15.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001069899
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
dei Entity Registrant Name
EntityRegistrantName
PHIBRO ANIMAL HEALTH CORP
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2021Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2023-02-28
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36410
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1840497
dei Entity Address Address Line1
EntityAddressAddressLine1
Glenpointe Centre East, 3rd Floor
dei Entity Address Address Line2
EntityAddressAddressLine2
300 Frank W. Burr Boulevard, Suite 21
dei Entity Address City Or Town
EntityAddressCityOrTown
Teaneck
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07666-6712
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
329-7300
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
PAHC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Revenues
Revenues
232712000
CY2020Q4 us-gaap Revenues
Revenues
206149000
us-gaap Revenues
Revenues
447377000
us-gaap Revenues
Revenues
401343000
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
162040000
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
137884000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
312027000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
268959000
CY2021Q4 us-gaap Gross Profit
GrossProfit
70672000
CY2020Q4 us-gaap Gross Profit
GrossProfit
68265000
us-gaap Gross Profit
GrossProfit
135350000
us-gaap Gross Profit
GrossProfit
132384000
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48378000
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48375000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
98444000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
96806000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
22294000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
19890000
us-gaap Operating Income Loss
OperatingIncomeLoss
36906000
us-gaap Operating Income Loss
OperatingIncomeLoss
35578000
CY2021Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2953000
CY2020Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3214000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5842000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6024000
CY2021Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4189000
CY2020Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-624000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2061000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3007000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23530000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16052000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33125000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32561000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6065000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3251000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9126000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7458000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
17465000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
12801000
us-gaap Net Income Loss
NetIncomeLoss
23999000
us-gaap Net Income Loss
NetIncomeLoss
25103000
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
17465000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
12801000
us-gaap Net Income Loss
NetIncomeLoss
23999000
us-gaap Net Income Loss
NetIncomeLoss
25103000
CY2021Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
4810000
CY2020Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
3729000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
4781000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
4818000
CY2021Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-10311000
CY2020Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
9500000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-17275000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
4777000
CY2021Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-117000
CY2020Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-137000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-234000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-272000
CY2021Q4 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1231000
CY2020Q4 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
966000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1253000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1272000
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6615000
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12400000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13513000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8595000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10850000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25201000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10486000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33698000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63385000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50212000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
32100000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
43000000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
142495000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
146852000
CY2021Q4 us-gaap Inventory Net
InventoryNet
230784000
CY2021Q2 us-gaap Inventory Net
InventoryNet
216312000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
39846000
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
42533000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
508610000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
498909000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
154584000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
154706000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
57971000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62282000
CY2021Q4 us-gaap Goodwill
Goodwill
52679000
CY2021Q2 us-gaap Goodwill
Goodwill
52679000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75114000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72749000
CY2021Q4 us-gaap Assets
Assets
848958000
CY2021Q2 us-gaap Assets
Assets
841325000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
13125000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
9375000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
80663000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
68362000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72840000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86379000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
166628000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
164116000
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
107000000
CY2021Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
95000000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
280317000
CY2021Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
287710000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55719000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55970000
CY2021Q4 us-gaap Liabilities
Liabilities
609664000
CY2021Q2 us-gaap Liabilities
Liabilities
602796000
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2021Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
135803000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
135803000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
232293000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
218015000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-128806000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115293000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
239294000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
238529000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
848958000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
841325000
us-gaap Net Income Loss
NetIncomeLoss
23999000
us-gaap Net Income Loss
NetIncomeLoss
25103000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15855000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16124000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
295000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
441000
us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Share Based Compensation
ShareBasedCompensation
1129000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-537000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-201000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
2890000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
7174000
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-259000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-258000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1427000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2633000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21975000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10514000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
561000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1327000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2578000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-97000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13859000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-285000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2007000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2327000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23943000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28611000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
32100000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
31000000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
43000000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
25000000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
15139000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
14738000
us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
1353000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
212000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
521000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3098000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21259000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
163000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
76000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
151000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
67000000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-3750000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-9375000
us-gaap Payments Of Dividends
PaymentsOfDividends
9721000
us-gaap Payments Of Dividends
PaymentsOfDividends
9709000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4840000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6311000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10084000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-1361000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
923000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13173000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1809000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50212000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36343000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63385000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34534000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
238529000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-364000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2021Q3 us-gaap Dividends
Dividends
4860000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
233305000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10850000
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2021Q4 us-gaap Dividends
Dividends
4861000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
239294000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
188204000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8497000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q3 us-gaap Dividends
Dividends
4854000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
565000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
192412000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25201000
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q4 us-gaap Dividends
Dividends
4855000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
564000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
213322000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">1.  Description of Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, dairy and beef cattle, swine, and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The unaudited consolidated financial information for the three and six months ended December 31, 2021 and 2020, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 (the “Annual Report”), filed with the Securities and Exchange Commission on August 25, 2021 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2021, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain. Although vaccines are now available, distribution efforts vary widely country-by-country and state-by-state. New information may continue to emerge concerning COVID-19, and the actions required to contain or treat it may affect the duration and severity of the pandemic. The pandemic may have significant economic impacts on customers, suppliers and markets. The pandemic may affect our future revenues, expenses, reserves and allowances, manufacturing operations and employee-related costs. Our financial statements include estimates of the effects of COVID-19 and there may be changes to those estimates in future periods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p>
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
17465000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
12801000
us-gaap Net Income Loss
NetIncomeLoss
23999000
us-gaap Net Income Loss
NetIncomeLoss
25103000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2020Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
50000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
50000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2021Q4 pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
232712000
CY2020Q4 pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
206149000
pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
447377000
pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
401343000
CY2021Q4 pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
232712000
CY2020Q4 pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
206149000
pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
447377000
pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
401343000
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
3024000
CY2021Q2 us-gaap Deferred Revenue
DeferredRevenue
3674000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1675000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1560000
CY2021Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
147000
CY2020Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
220000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
295000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
441000
CY2021Q4 us-gaap Interest Expense Other
InterestExpenseOther
44000
CY2020Q4 us-gaap Interest Expense Other
InterestExpenseOther
59000
us-gaap Interest Expense Other
InterestExpenseOther
89000
us-gaap Interest Expense Other
InterestExpenseOther
126000
CY2021Q4 us-gaap Interest Expense
InterestExpense
3102000
CY2020Q4 us-gaap Interest Expense
InterestExpense
3476000
us-gaap Interest Expense
InterestExpense
6167000
us-gaap Interest Expense
InterestExpense
6585000
CY2021Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
149000
CY2020Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
262000
us-gaap Interest And Other Income
InterestAndOtherIncome
325000
us-gaap Interest And Other Income
InterestAndOtherIncome
561000
CY2021Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2953000
CY2020Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3214000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5842000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6024000
CY2021Q4 us-gaap Depreciation
Depreciation
5864000
CY2020Q4 us-gaap Depreciation
Depreciation
5885000
us-gaap Depreciation
Depreciation
11578000
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
59775000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11886000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12738000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
147612000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
143799000
CY2021Q4 us-gaap Inventory Net
InventoryNet
230784000
CY2021Q2 us-gaap Deposits Assets
DepositsAssets
5663000
CY2021Q4 pahc Insurance Investment
InsuranceInvestment
6054000
CY2021Q2 us-gaap Inventory Net
InventoryNet
216312000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32253000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32962000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8187000
CY2021Q2 pahc Insurance Investment
InsuranceInvestment
5964000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4717000
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
4141000
CY2021Q4 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
5608000
CY2021Q2 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
2696000
CY2021Q4 pahc Pension And Other Postretirement And Postemployment Benefit Plans Assets Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansAssetsNoncurrent
2048000
CY2021Q2 pahc Pension And Other Postretirement And Postemployment Benefit Plans Assets Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansAssetsNoncurrent
1184000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1623000
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1811000
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
9389000
CY2021Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
8467000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75114000
us-gaap Depreciation
Depreciation
11716000
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2137000
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2203000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72749000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
27867000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35375000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6601000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6618000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4277000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4408000
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8001000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9861000
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
5235000
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
6005000
CY2021Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
6312000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4637000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4380000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
6532000
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
6107000
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1590000
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3486000
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8088000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15855000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16124000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
71286000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4840000
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0
CY2021Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
735000
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1218000
CY2021Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1176000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18390000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17350000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72840000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86379000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27694000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28003000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8064000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6646000
CY2021Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8631000
CY2021Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8382000
CY2021Q4 pahc International Retirement Plans
InternationalRetirementPlans
5427000
CY2021Q2 pahc International Retirement Plans
InternationalRetirementPlans
5345000
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
27000
CY2021Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
5876000
CY2021Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
7594000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55719000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55970000
CY2021Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
3991000
CY2021Q2 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-790000
CY2021Q4 pahc Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Before Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
-117370000
CY2021Q2 pahc Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Before Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
-100095000
CY2021Q4 pahc Accumulated Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Tax
AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax
19739000
CY2021Q2 pahc Accumulated Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Tax
AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax
19973000
CY2021Q4 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments
-1098000
CY2021Q2 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments
97000
CY2021Q4 pahc Income Tax Provision Benefit On Long Term Intercompany Loans
IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans
8166000
CY2021Q2 pahc Income Tax Provision Benefit On Long Term Intercompany Loans
IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans
8166000
CY2021Q4 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses
-2756000
CY2021Q2 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses
-2698000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-128806000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115293000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
294375000
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
298125000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
933000
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1040000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
293442000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
297085000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
13125000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
9375000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
280317000
CY2021Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
287710000
pahc Number Of Potentially Responsible Parties
NumberOfPotentiallyResponsibleParties
140
CY2022Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
300000000
CY2022Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
300000000
CY2021Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4840000
CY2021Q4 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1203000
CY2020Q4 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1203000
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
564000
us-gaap Share Based Compensation
ShareBasedCompensation
1129000
CY2021Q4 pahc Segment Assets
SegmentAssets
848958000
CY2021Q2 pahc Segment Assets
SegmentAssets
841325000

Files In Submission

Name View Source Status
0001410578-22-000100-index-headers.html Edgar Link pending
0001410578-22-000100-index.html Edgar Link pending
0001410578-22-000100.txt Edgar Link pending
0001410578-22-000100-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pahc-20211231.xsd Edgar Link pending
pahc-20211231x10q.htm Edgar Link pending
pahc-20211231x10q_htm.xml Edgar Link completed
pahc-20211231xex10d25.htm Edgar Link pending
pahc-20211231xex10d25001.jpg Edgar Link pending
pahc-20211231xex10d25002.jpg Edgar Link pending
pahc-20211231xex31d1.htm Edgar Link pending
pahc-20211231xex31d2.htm Edgar Link pending
pahc-20211231xex32d1.htm Edgar Link pending
pahc-20211231xex32d2.htm Edgar Link pending
pahc-20211231_cal.xml Edgar Link unprocessable
pahc-20211231_def.xml Edgar Link unprocessable
pahc-20211231_lab.xml Edgar Link unprocessable
pahc-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending